Enteric fever, caused by Salmonella enterica serovars Typhi and Paratyphi, remains a significant global health concern. This article aims to provide a comprehensive guide to an integrated approach for its diagnosis and clinical management.
Diagnosing enteric fever involves isolating the bacteria from blood, bone marrow, or specific lesions. However, these methods can be time-consuming and lack sensitivity. Recent advances include molecular diagnostic techniques, such as polymerase chain reaction (PCR), which offer rapid and accurate identification. Serological tests, while less specific, can be useful in low-resource settings or when cultures are unavailable.
Antimicrobial therapy remains the cornerstone of enteric fever management. Fluoroquinolones, third-generation cephalosporins, and azithromycin are commonly used. However, increasing antimicrobial resistance necessitates regular susceptibility testing and judicious use of antibiotics.
Supportive care plays a critical role in managing complications and improving patient outcomes. This includes hydration, nutritional support, and management of symptoms such as fever and pain. Close monitoring for potential complications, such as intestinal perforation or neurologic manifestations, is essential.
Vaccination is a crucial preventive measure, particularly in endemic regions. Two vaccines are currently available: the injectable Vi polysaccharide vaccine and the oral Ty21a vaccine. Both have demonstrated efficacy, although neither provides complete protection.
The management of enteric fever requires a comprehensive, integrated approach that considers accurate diagnosis, effective antimicrobial therapy, supportive care, and preventive measures such as vaccination. As the landscape of antimicrobial resistance evolves, ongoing research and development of new diagnostic methods, therapeutics, and vaccines will be crucial to maintaining progress against this global health threat.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation